Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Patch 5% in Carpal Tunnel Syndrome
NCT00266214Phase 3Terminated
- Sponsor
- Endo International plc
- Start
- Nov 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in carpal tunnel syndrome (CTS) (2 arms), sponsored by Endo International plc. Primary endpoint: Worst daily pain intensity score at Week 8. Started Nov 2005; status: terminated.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT00266214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266214.